Independent payment processing and financial technology company Lead:Citigroup, Credit Suisse, Goldman Sachs Co manager: BofA Securities, Morgan Stanley, RBC Capital Markets, Evercore ISI, Raymond James, Suntrust Robinson Humphrey, Wolfe Capital, TD Securities, Telsey Advisory Group
great growth potential, If my missed the run up like I did this may be our chance!
Benefitfocus, Inc. engages in the provision of cloud-based benefits management platform for consumers, employers, insurance carriers, and brokers BuildGroup Management reports 14.3% active stake in BNFT
EV/Sales Consensus.. sitting at 5.1x WHY QCOM?? Qualcomm pushes 5G tech into chips for cheaper phones June 16 (Reuters) - Qualcomm Inc on Tuesday said it is putting 5G technology into chips for smartphones that will sell for as little as $300 and that will come to market in the second half of this year. San Diego-based Qualcomm is the biggest supplier of...
Mastech Digital (MHH #2) is a leading provider of Digital Transformation IT Services. On its Data and Analytics Services segment, MHH sees this segment as having huge potential. The company has been seeing good traction for its expanded service offerings globally. In 2020, this segment's main goal is to broaden its geographical reach beyond North America into...
Okta announced the pricing of $1.0 bln aggregate principal amount of Convertible Senior Notes due 2026 (180.07) The notes will be senior, unsecured obligations of Okta. The notes will bear interest at a rate of 0.375% per year. Interest will be payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2020. The notes...
RECENT NEWS SDC (7.12 -7.75%): Missed expectations for Q1 EPS and revs. Q1 unique aligner shipments rose +12% yr/yr to 122,751. During its call, co noted that it shipped 10,500 aligner orders in April and between 11,000-15,000 in May; it projects the current run rate to be circa 22,000 shipments in a 30-day period. Co commented that since Q1, it has seen "robust...
Easy breakout play! Will take some far out calls!
Personally got stopped out of that position during COVID-19 Looking really good for a continuation!
Solid fundamentals with breakout potential! Regained the entire pre-Covid decline!
21-May-20 16:10 ET AMRN Amarin announces trial to evaluate effects of VASCEPA on patients with COVID-19 (7.28 -0.18) Amarin today announced support for a clinical trial to investigate the effects of icosapent ethyl (IPE) (VASCEPA) on inflammatory biomarkers and other patient outcomes in individuals with COVID-19. The trial primary endpoint is the effect of...
Easy money potential!
Easily the top stock to keep an eye on, personally took some Mar 2021 LEAPs Strong support, people have been buying for the last 4 quarters! And with the new battery review this can fly!!
Easy play at a deep accumulation zone watch that purple line to act as resistance
Easy break out potential! Tight stops, Market was weak today yet this stock held well!
With the new product lines being leaked and enticing investors, This break out will be MASSIVE!!! PT 67
Currently trading at a steal based on growth metrics. my model suggests a FY21 EBITDA Margin growth 19% for & FY21 FCF/share = $1.08 Currently trading at: 1.4x EV/Sales 7.9x EV/EBITDA 17% EBIDTA Margins